Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew A Gubens

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
The Oncologist|December 10, 2024
Associations of frailty with survival, hospitalization, functional decline, and toxicity among older adults with advanced non-small cell lung cancerHoward J Lee, John Boscardin, Louise C Walter, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2023
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitisPooja Middha, Rohit Thummalapalli, Michael J Betti, et al.
Nature Communications|March 27, 2024
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitisPooja Middha, Rohit Thummalapalli, Michael J Betti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 19, 2024
Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Phase II Multicenter StudyCollin M Blakely, Anatoly Urisman, Matthew A Gubens, et al.
Nature Genetics|November 7, 2017
Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancersCollin M Blakely, Thomas B K Watkins, Wei Wu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 17, 2018
NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018Gregory P Kalemkerian, Billy W Loo, Wallace Akerley, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 15, 2018
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 5.2018David S Ettinger, Dara L Aisner, Douglas E Wood, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 14, 2017
Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in OncologyDavid S Ettinger, Douglas E Wood, Dara L Aisner, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 6, 2019
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 1.2020David S Ettinger, Douglas E Wood, Charu Aggarwal, et al.
Cancer Immunology Research|April 16, 2017
Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLCPaul C Tumeh, Matthew D Hellmann, Omid Hamid, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
The Oncologist|December 10, 2024
Associations of frailty with survival, hospitalization, functional decline, and toxicity among older adults with advanced non-small cell lung cancerHoward J Lee, John Boscardin, Louise C Walter, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2023
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitisPooja Middha, Rohit Thummalapalli, Michael J Betti, et al.
Nature Communications|March 27, 2024
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitisPooja Middha, Rohit Thummalapalli, Michael J Betti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 19, 2024
Neoadjuvant Osimertinib for the Treatment of Stage I-IIIA Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Phase II Multicenter StudyCollin M Blakely, Anatoly Urisman, Matthew A Gubens, et al.
Nature Genetics|November 7, 2017
Evolution and clinical impact of co-occurring genetic alterations in advanced-stage EGFR-mutant lung cancersCollin M Blakely, Thomas B K Watkins, Wei Wu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 17, 2018
NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018Gregory P Kalemkerian, Billy W Loo, Wallace Akerley, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 15, 2018
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 5.2018David S Ettinger, Dara L Aisner, Douglas E Wood, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 14, 2017
Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in OncologyDavid S Ettinger, Douglas E Wood, Dara L Aisner, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 6, 2019
NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 1.2020David S Ettinger, Douglas E Wood, Charu Aggarwal, et al.
Cancer Immunology Research|April 16, 2017
Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLCPaul C Tumeh, Matthew D Hellmann, Omid Hamid, et al.
Pageof 6